Correction: panjideh et al. improved therapy of b-cell non-hodgkin lymphoma by obinutuzumab-dianthin conjugates in combination with the endosomal escape enhancer so1861. toxins 2022, 14,

HIGHLIGHTS

  • who: Hossein Panjideh and collaborators from the Universitu00e4t Pathobiochemistry, Augustenburger Platz, Berlin, Germany have published the research: Correction: Panjideh et al. Improved Therapy of B-Cell Non-Hodgkin Lymphoma by Obinutuzumab-Dianthin Conjugates in Combination with the Endosomal Escape Enhancer SO1861. Toxins 2022, 14,, in the Journal: Alanine aminotransferase asparagine aminotransferase glutamate dehydrogenase cholinesterase Toxins 2022, 14, 703. of 10/Oct/2022

SUMMARY

    Received Published: 13 October 2022 Publisher`s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. (a) (b) Toxins 2022, 14, 703 2 of . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?